Biology

SMi discloses £6 million seed funding round

22-Jun-2023 By Isabel Cameron

SMi Systems, a company specializing in single molecule imaging and quantification technologies, has disclosed a £6m seed funding round to develop the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.

NIH funds consortium to establish center for biomedical modeling

31-Aug-2018 By Maggie Lynch

The National Institute of Health (NIH) awarded $6.5m to a consortium of universities to create the Center for Reproducible Biomedical Modeling.

Lonza sets up innovation collaboration centre in Israel

09-Oct-2017 By Gareth Macdonald

Lonza has set up an innovation centre in Israel to tap local bioscience and software expertise to bolster its Pharma&Biotech business.

Thermo Fisher bags single-use bioreactor tech partner Finesse

14-Feb-2017 By Dan Stanton

Thermo Fisher Scientific says it is buying Finesse Solutions, its long-term supplier of measurement and control solutions for bioprocessing applications.

Bio-synonyms: describing biosimilars without saying ‘copycats’ or ‘knock-offs’

21-Oct-2016 By Dan Stanton

Terms such as ‘copycats’ and ‘knock-offs’ are inaccurate and misleading, say drugmakers. We ask therefore how industry and the media should refer to biosimilar products?

Lonza: Biologic APIs boosted H1 revs and CAR-T deal will help sustain growth in H2

20-Jul-2016 By Gareth Macdonald

Lonza has increased its 2016 earnings guidance after strong H1 growth of its biologic APIs business.

UK's commercial DNA foundry a step on path to 'bioeconomy'

05-Jul-2016 By Phil Taylor

The opening of the UK's first synthetic biology foundry promises to usher in a new era of cheaper and more accessible DNA synthesis.

Thermo Fisher strengthens antibody services through Affymetrix merger

01-Apr-2016 By Dan Stanton

Thermo Fisher has expanded its life sciences tools business through the acquisition of biological analysis firm Affymetrix for $1.3bn.

Danaher Q4: Life science demand and single-use growth attest Pall buy

27-Jan-2016 By Dan Stanton

Four months since acquiring Pall Corporation, Danaher has reported a 34% year-on-year increase in sales from its life sciences segment.

Thermo Fisher to expand cellular analysis toolbelt in $1.3bn 'sensible' deal

12-Jan-2016 By Dan Stanton

Thermo Fisher will expand its antibody, multiplex RNA, and protein analysis tech offerings through the $1.3bn acquisition of Affymetrix.

Immunotherapy in the UK? National manufacturing site backed by GE

17-Dec-2014 By Dan Stanton

GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.

Indian budget sets out country's biotechology drive

11-Jul-2014 By Dan Stanton

India is looking to stimulate investment in biotechnology through bioclusters and development of the International Centre for Genetic Engineering and Biotechnology (ICGEB).